| Predictive factor for COVID-19 worsening: insights for high-sensitivity troponin and D-dimer and correlation with right ventricular afterload G Goudot, R Chocron, JL Augy, N Gendron, L Khider, B Debuc, ... Frontiers in medicine 7, 586307, 2020 | 40 | 2020 |
| Lupus anticoagulant single positivity during the acute phase of COVID‐19 is not associated with venous thromboembolism or In‐hospital mortality N Gendron, MA Dragon‐Durey, R Chocron, L Darnige, G Jourdi, ... Arthritis & Rheumatology 73 (11), 1976-1985, 2021 | 32 | 2021 |
| The complex karyotype and chronic lymphocytic leukemia: prognostic value and diagnostic recommendations L Jondreville, D Krzisch, E Chapiro, F Nguyen‐Khac American Journal of Hematology 95 (11), 1361-1367, 2020 | 28 | 2020 |
| Cytogenetic and molecular abnormalities in W aldenström's macroglobulinemia patients: Correlations and prognostic impact D Krzisch, N Guedes, C Boccon‐Gibod, M Baron, C Bravetti, F Davi, ... American Journal of Hematology 96 (12), 1569-1579, 2021 | 25 | 2021 |
| Successful treatment of Trichosporon asahii fungemia with isavuconazole in a patient with hematologic malignancies G Feugray, D Krzisch, M Dehais, R Razakandrainibe, G Gargala, ... Infection and drug resistance, 2015-2018, 2019 | 16 | 2019 |
| The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients H Ghesquières, D Krzisch, E Nicolas-Virelizier, S Kanoun, AC Gac, ... Blood 143 (11), 983-995, 2024 | 4 | 2024 |
| Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation N Forgeard, M Baron, J Caron, C Boccon-Gibod, D Krzisch, N Guedes, ... Haematologica 107 (11), 2720, 2022 | 3 | 2022 |
| Fatal invasive trichosporonosis caused by Trichosporon inkin after allogeneic stem cell transplant for very severe idiopathic aplastic anemia D Krzisch, V Camus, M David, G Gargala, S Lepretre Journal of Bacteriology & Parasitology 10 (5), 2019 | 3 | 2019 |
| Successful treatment of T/myeloid mixed‐phenotype acute leukemia with the translocation (10;11)(p13;q14) PICALM/AF10 with 3 + 7 myeloid standard treatment: A … D Krzisch, A Zduniak, EL Veresezan, S Daliphard, N Contentin, D Penther, ... Clinical Case Reports 9 (3), 1507-1513, 2021 | 2 | 2021 |
| Waldenström disease: News and perspectives in 2022 F Bouclet, D Krzisch, V Leblond, C Tomowiak, K Laribi, L Ysebaert, ... Bulletin du Cancer, S0007-4551 (22) 00350, 2022 | 1 | 2022 |
| Évolution des stratégies thérapeutiques au rythme de la compréhension moléculaire au sein de la macroglobulinémie de Waldenström. D Roos-Weil, D Krzisch Hematologie 29, 2023 | | 2023 |
| Evolution of therapeutic strategies at the pace of molecular understanding in Waldenström Macroglobulinemia D Roos-Weil, D Krzisch Hématologie 29 (1), 14-22, 2023 | | 2023 |
| Maladie de Waldenström: actualités et perspectives en 2022 F Bouclet, D Krzisch, V Leblond, C Tomowiak, K Laribi, L Ysebaert, ... Bulletin du Cancer 110 (1), 88-100, 2023 | | 2023 |
| Prognostic relevance of lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience J Pénichoux, S Dubois, D Krzisch, AL Menard, H Lanic, V Camus, ... Leukemia & Lymphoma 62 (9), 2272-2275, 2021 | | 2021 |
| Prognostic Value of Lymphocyte-Monocyte Ratio in Primary Myelodysplastic Syndrome A Stamatoullas, PJ Viailly, D Krzisch, B Marcq, A Curie, E Lemasle, ... Leukemia Research 1 (55), S153, 2017 | | 2017 |
